MNMD Stock Analysis: Buy, Sell, or Hold?
MNMD - Mind Medicine (MindMed) Inc. Common Shares
$15.02
0.15 (1.01%)
â˛
5d:
+7.06%
30d:
+19.54%
90d:
+19.02%
WAIT
LOW Confidence
Analysis Updated: Jan 14, 2026 12:00 AM ET
Earnings: May 07, 2026
0d
Get Alerted When MNMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: MNMD is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: MNMD is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: MNMD is currently trading at $15.02, which is considered fair based on recent price action.
Technical Outlook: Technically, MNMD is in a strong uptrend. The price is approaching resistance at $15.29. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: MNMD scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $28.67 (+90.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MNMD is in a strong uptrend. The price is approaching resistance at $15.29. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: MNMD scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $28.67 (+90.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
43/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
81.6%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (75/100)
- BULLISH: Trading 90.9% below Wall St target ($28.67)
- WARNING: Composite score 43/100 in the bottom quintile â this cohort historically lags the market
Support & Resistance Levels
Support Level
$12.88
Resistance Level
$15.29
Current Trend
Strong Uptrend
Technical data as of
Jan 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-8.47
Wall Street Target
$28.67
(+90.9%)
Share & Embed Analysis
Last updated: September 12, 2026 5:46 AM ET
Data refreshes hourly during market hours. Next update: 6:46 AM
Data refreshes hourly during market hours. Next update: 6:46 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MNMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$49 | 44 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1180 | 43 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 34 SELL |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$135 | 47 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 39 SELL |
